28 June 2022>: Clinical Research
Impact of a Rehabilitation Program on the Change in Components of Body Mass of the Upper and Lower Limbs in People After Ischemic Stroke
Grzegorz Przysada 1ACDF , Justyna Leszczak 2ABEF* , Joanna Baran 2CDE , Andżelina Wolan-Nieroda 2BDF , Bogumiła Pniak 3CDE , Viliam Knap 4BDF , Mariusz Drużbicki 2ADF , Agnieszka Guzik 2ADEDOI: 10.12659/MSM.936397
Med Sci Monit 2022; 28:e936397
Table 4 The effect of rehabilitation on the amount of muscle mass in age groups 25 to 44 and 45 to 60 years.
Age | Side of paresis | Exam | N | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PMM | PMM right lower limb | PMM left lower limb | PMM right arm | PMM left arm | ||||||||||||||
25–44 years | Left | Exam I | 5 | 69.20 | 3.74 | 0.096*** | 40.02 | 2.00 | 0.527*** | 41.38 | 4.72 | 0.552*** | 40.95 | 3.88 | 0.010*** | 41.75 | 3.78 | 0.265*** |
Exam II | 5 | 75.58 | 9.19 | 41.18 | 4.35 | 41.28 | 4.53 | 41.68 | 3.69 | 41.97 | 3.67 | |||||||
Right | Exam I | 6 | 69.88 | 6.66 | 0.732*** | 40.32 | 3.44 | 0.577*** | 39.21 | 3.66 | 0.674*** | 41.10 | 4.33 | 0.207*** | 41.50 | 5.29 | 0.560*** | |
Exam II | 6 | 71.73 | 8.64 | 38.74 | 4.44 | 39.30 | 3.56 | 41.75 | 4.51 | 41.63 | 5.03 | |||||||
25–44 years | Left | Exam II | 5 | 75.58 | 9.19 | 0.701*** | 41.18 | 4.35 | 0.672*** | 41.28 | 4.53 | 0.666*** | 41.68 | 3.69 | 0.737*** | 41.97 | 3.67 | 0.779*** |
Exam III | 5 | 72.73 | 12.85 | 39.86 | 4.14 | 39.92 | 4.06 | 42.65 | 4.34 | 42.93 | 4.96 | |||||||
Right | Exam II | 6 | 71.73 | 8.64 | 0.443*** | 38.74 | 4.44 | 0.651*** | 39.30 | 3.56 | 0.741*** | 41.75 | 4.51 | 0.883*** | 41.63 | 5.03 | 0.990*** | |
Exam III | 6 | 78.81 | 24.78 | 39.65 | 3.76 | 39.90 | 3.49 | 41.36 | 3.03 | 41.67 | 2.94 | |||||||
45–60 years | Left | Exam I | 16 | 70.44 | 7.67 | 0.973*** | 41.44 | 3.83 | 0.482*** | 41.62* | 37.37–44.17* | 0.077** | 42.58* | 40.70–44.34* | 0.278** | 42.26* | 40.73–44.04* | 0.929** |
Exam II | 16 | 70.54 | 7.86 | 40.39 | 3.91 | 41.31* | 38.45–43.13* | 41.75* | 40.08–44.64* | 42.31* | 40.14–43.96* | |||||||
Right | Exam I | 12 | 71.64 | 4.54 | 0.925*** | 39.91 | 3.10 | 0.327*** | 41.90* | 40.08–42.95* | 0.859** | 42.28 | 1.69 | 0.823*** | 41.94 | 1.93 | 0.051*** | |
Exam II | 12 | 71.79 | 4.07 | 41.11 | 2.20 | 41.92* | 39.75–42.68* | 42.22 | 1.99 | 42.30 | 1.98 | |||||||
45–60 years | Left | Exam II | 16 | 71.06* | 66.47–76.67* | 0.049* | 40.39 | 3.91 | 0.473 | 40.41 | 3.98 | 0.500*** | 41.58 | 3.34 | 0.136*** | 41.60 | 3.20 | 0.605*** |
Exam III | 16 | 63.29* | 52.42–73.64* | 41.00 | 3.25 | 41.03 | 3.33 | 43.04 | 2.51 | 42.06 | 2.71 | |||||||
Right | Exam II | 12 | 71.79 | 4.07 | 0.377 | 41.11 | 2.20 | 0.813 | 41.41 | 1.99 | 0.799*** | 42.22 | 1.99 | 0.724*** | 42.30 | 1.98 | 0.791*** | |
Exam III | 12 | 76.11 | 17.91 | 40.90 | 3.00 | 41.17 | 3.04 | 41.91 | 2.69 | 42.02 | 3.09 | |||||||
* Median (Q1–Q3); ** Wilcoxon test; *** T-test. |